GAVISCON, oral suspension in a sachet 24 sachets of 10 ml
Active ingredients: Sodium alginate, Sodium bicarbonate
Commercialized according to BDPM
Oral suspension24 sachets of 10 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GAVISCON, suspension buvable en sachet
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 24 sachet(s) aluminium polyéthylène de 10 ml
- Marketing authorisation holder
- RECKITT BENCKISER HEALTHCARE FRANCE
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Oct 1989
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66116589CIP73309525CIP133400933095253Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SODIUM (BICARBONATE DE)suspension | 267 mg · un sachet-dose | SA |
| SODIUM (ALGINATE DE)suspension | 500 mg · un sachet-dose | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.